Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
NamPhuong Tran
Janssen Research & Development, LLC
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
90
TOTAL CITATIONS
2
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Final Analysis of LATITUDE, a Phase 3 Study of Abiraterone Acetate Plus Prednisone in Patients with Newly Diagnosed High-Risk Metastatic Castration-Sensitive Prostate Cancer
Number of pages: 178
Posted: 08 Jan 2019
Karim Fizazi
, NamPhuong Tran,
Luis Fein
,
Nobuaki Matsubara
,
Alfredo Rodriguez-Antolin
,
Boris Y. Alekseev
,
Mustafa Özgüroğlu
,
Dingwei Ye
,
Susan Feyerabend
,
Andrew Protheroe
,
Giri Sulur
,
Yesenia Luna
,
Susan Li
,
Suneel Mundle
and
Kim N. Chi
Université Paris XI Sud - Gustave Roussy Cancer Campus, Janssen Research & Development, LLC, Institute of Oncology of Rosario, National Cancer Center Hospital East, 612 de Octubre University Hospital, PA Hertsen Moscow Cancer Research Institute, Istanbul University, Fudan University - Shanghai Cancer Center (FUSCC), Studienpraxis Urologie, University of Oxford, Janssen Research & Development, LLC, Janssen Research & Development, LLC, Janssen Research & Development, LLC, Janssen Research & Development, LLC and BC Cancer Agency (BCCA)
Downloads
90
(742,061)
Citation
2
View PDF
Download
Abstract:
abiraterone acetate, metastatic castration-naive prostate cancer, overall survival
Feedback